Target Name: MIR1270
NCBI ID: G100302179
Review Report on MIR1270 Target / Biomarker Content of Review Report on MIR1270 Target / Biomarker
MIR1270
Other Name(s): microRNA 1270 | mir-1270 | hsa-mir-1270-1 | MIR1270-1 | Hsa-mir-1270 | hsa-miR-1270 | MicroRNA 1270 | Hsa-mir-1270-1 | MIR1270-2 | hsa-mir-1270 | MIRN1270

MIR1270: A Potential Drug Target and Biomarker

Mir1270, a non-coding RNA molecule, has been identified as a potential drug target and biomarker in various diseases, including cancer. Its unique structure and function have made it an attractive target for drug development. In this article, we will discuss the research on MIR1270 and its potential as a drug target and biomarker.

Structure and Function

MIR1270 is a microRNA (miRNA), which is a non-coding RNA molecule that plays a crucial role in post-transcriptional gene regulation. It is expressed in various tissues and cells and is involved in regulating gene expression, cell growth, and differentiation.

MIR1270 is a perfect candidate for a drug target because of its unique structure and function. It has a unique 29-amino acid sequence at its ends, which is not found in any other miRNA. This sequence is known as a leader region and is involved in the formation of a stable double-stranded RNA molecule.

MIR1270 has also been shown to have a variety of functions, including regulating gene expression, cell growth, and differentiation. It has been shown to be involved in the regulation of various cellular processes, including cell cycle progression, apoptosis, and cell signaling pathways.

MIR1270 as a Drug Target

MIR1270 is a potential drug target due to its unique structure and function. Its leader region and unique 29-amino acid sequence make it an attractive target for small molecule inhibitors. These inhibitors can target the stability of the double-stranded RNA molecule, leading to the inhibition of MIR1270 function.

MIR1270 has also been shown to play a role in cancer progression. Several studies have shown that MIR1270 is overexpressed in various types of cancer, including breast, lung, and colon cancer. This overexpression is associated with poor prognosis and increased disease severity.

In addition, MIR1270 has also been shown to be involved in the regulation of cellular signaling pathways. It has been shown to play a role in the regulation of the PI3K/Akt signaling pathway, which is involved in cell signaling pathways. This suggests that MIR1270 may be a useful target for inhibitors of this pathway, which could be useful for the treatment of various diseases.

MIR1270 as a Biomarker

MIR1270 can also be used as a biomarker for various diseases. Its unique structure and function make it an attractive target for diagnostic tools, such as qRT-PCR, a reverse transcription polymerase technique.

MIR1270 has been shown to be expressed in various types of cancer, including breast, lung, and colon cancer. This suggests that it may be a useful biomarker for these diseases. In addition, MIR1270 has also been shown to be involved in the regulation of cellular signaling pathways, which may be involved in the development of various diseases.

Conclusion

MIR1270 is a unique non-coding RNA molecule that has been shown to have a variety of functions, including regulating gene expression, cell growth, and differentiation. Its unique structure and function make it an attractive target for drug development. Its potential as a drug target and biomarker make it an attractive target for further research.

Future studies are needed to fully understand the functions of MIR1270 and its potential as a drug target and biomarker. More research is also needed to develop small molecule inhibitors that can specifically target the leader region of MIR1270 and inhibit its function. With further research, MIR1270 may be a valuable tool for the treatment of various diseases.

Protein Name: MicroRNA 1270

The "MIR1270 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR1270 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR1271 | MIR1272 | MIR1273A | MIR1273C | MIR1273H | MIR1275 | MIR1276 | MIR1277 | MIR1278 | MIR1279 | MIR128-1 | MIR128-2 | MIR1280 | MIR1281 | MIR1282 | MIR1283-1 | MIR1283-2 | MIR1284 | MIR1285-1 | MIR1285-2 | MIR1286 | MIR1287 | MIR1288 | MIR1289-1 | MIR1289-2 | MIR129-1 | MIR129-2 | MIR1290 | MIR1291 | MIR1292 | MIR1293 | MIR1294 | MIR1295A | MIR1295B | MIR1296 | MIR1297 | MIR1298 | MIR1299 | MIR1301 | MIR1302-1 | MIR1302-10 | MIR1302-11 | MIR1302-2 | MIR1302-3 | MIR1302-4 | MIR1302-5 | MIR1302-6 | MIR1302-7 | MIR1302-8 | MIR1302-9 | MIR1303 | MIR1304 | MIR1305 | MIR1306 | MIR1307 | MIR130A | MIR130B | MIR132 | MIR1321 | MIR1322 | MIR1323 | MIR1324 | MIR133A1 | MIR133A1HG | MIR133A2 | MIR133B | MIR134 | MIR1343 | MIR135A1 | MIR135A2 | MIR135B | MIR136 | MIR137 | MIR137HG | MIR138-1 | MIR138-2 | MIR139 | MIR140 | MIR141 | MIR142 | MIR143 | MIR144 | MIR145 | MIR1468 | MIR1469 | MIR146A | MIR146B | MIR1470 | MIR1471 | MIR147A | MIR147B | MIR148A | MIR148B | MIR149 | MIR150 | MIR151A | MIR151B | MIR152 | MIR153-1 | MIR153-2